KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Long-Term Investments (2016 - 2026)

Chemed filings provide 18 years of Long-Term Investments readings, the most recent being $143.8 million for Q1 2026.

  • For the quarter ending Q1 2026, Long-Term Investments rose 12.37% year-over-year to $143.8 million, compared with a TTM value of $143.8 million through Mar 2026, up 12.37%, and an annual FY2025 reading of $140.3 million, up 7.17% over the prior year.
  • Long-Term Investments hit $143.8 million in Q1 2026 for Chemed, up from $140.3 million in the prior quarter.
  • The five-year high for Long-Term Investments was $143.8 million in Q1 2026, with the low at $90.1 million in Q3 2022.
  • Median Long-Term Investments over the past 5 years was $117.6 million (2024), compared with a mean of $115.3 million.
  • The sharpest move saw Long-Term Investments decreased 11.71% in 2022, then grew 23.4% in 2024.
  • Year by year, Long-Term Investments stood at $93.2 million in 2022, then rose by 13.87% to $106.1 million in 2023, then grew by 23.4% to $131.0 million in 2024, then increased by 7.17% to $140.3 million in 2025, then grew by 2.44% to $143.8 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $143.8 million, $140.3 million, and $136.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.